ORPHA:86836
Refractory cytopenia with multilineage dysplasia
- Type
- Clinical group
- Group
- Group of disorders
- Age of onset
- Adult
- Status
- active
Refractory cytopenias with multilineage dysplasia (RCMD) is a frequent subtype of myelodysplastic syndrome (MDS) characterized by 1 or more cytopenias in the peripheral blood and dysplasia in 2 or more myeloid lineages.
1
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Refractory cytopenia with multilineage dysplasia | |
| fr | Cytopénie réfractaire avec dysplasie multilignée | |
| de | Zytopenie, refraktäre mit multilineärer Dysplasie | |
| es | Citopenia refractaria con displasia multilineal | |
| it | Citopenia refrattaria con displasia multilineare | |
| nl | Refractaire cytopenie met multilineaire dysplasie | |
| pt | Citopenia refratária com displasia multilinear | |
| pl | Cytopenia oporna na leczenie z wieloliniową dysplazją | |
| cs | Refrakterní cytopenie s multilineární dysplázií | |
| uk | Рефрактерна цитопенія з мультилінійною дисплазією | |
| zh | 难治性血细胞减少伴多系发育异常 | |
| tr | Multilineage displazi ile seyreden refrakter sitopeni |
Definition in:
2
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| ICD-11 | 2A34 | E | specific | validated |
| MONDO | 19453 | E | validated | |
| UMLS | C0796466 | E | validated | |
| MedDRA | 10067959 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
3
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:52688Myelodysplastic syndrome
rare hematological diseases; rare neoplastic diseases; rare transplant-related disorders
4
Genes
0 directOrphanet records no gene directly on this code.
5
Prevalence and incidence
1 record| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Annual incidence | <1 / 1 000 000 | — | Europe | Class only | Validated | RARECARE surveillance of rare cancers in Europe[OTHER] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
6
HPO phenotypes
Orphanet has no HPO annotation for this code in this release.
7
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/86836
- This record as JSON: /data/d/86836.json